Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Clint Coghill’s Coghill Capital Management Reported 9.98% Passive Stake in $GMO

Clint Coghill’s Coghill Capital Management filed SEC 13G earlier today and revealed 9,065,360 shares in General Moly, Inc. (GMO), corresponding to a 9.98% passive stake. Coghill Capital Management does make change to its position after the second quarter. GMO has lost 50% so far this year. The stock is now pricing at $3.43.

According to Insider Monkey’s hedge fund tracking list, eight hedge funds invested in GMO in the third quarter. Beside Coghill Capital Management’s largest chunk, Stuart Peterson’s Artis Capital Management increased its position by 42% and reported 1.84 million shares at the end of September. Phil Falcone’s Harbinger had 1.40 million shares in GMO. Steven Cohen’s SAC Capital Advisors and David. E. Shaw’s D. E. Shaw sold out their GMO positions during the third quarter.


Coghill Capital Management is a Chicago-based hedge fund. The firm specializes in small cap value equity management. According to Linkedin, the firm provides services for Endowments, Foundations, Family Offices, High Net Worth Individuals, Pension Plans and Institutional Investors. The firm reported a $96 million 13F portfolio at the end of the third quarter. It mainly invests in Basic Materials and Technology sector.

According to Google Finance, General Moly, Inc. “is a development-stage company in the business of the exploration, development and mining of properties primarily containing molybdenum. The Company’s primary asset is 80% interest in the Mt. Hope Project (Mt. Hope Project), a primary molybdenum property, located in Eureka County, Nevada. As of December 31, 2009, the Mt. Hope Project had contained proven and probable molybdenum reserves totaling 1.3 billion pounds of which 1.1 billion pounds are estimated to be recoverable. In addition, it owns other non-core properties and mineral rights.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!